Skip to content
Medical Health Aged Care

Mudgee community turns out in force to support people impacted by dementia

Dementia Australia 2 mins read

Thank you to the Mudgee community members who turned up in force to the 2024 Memory Walk & Jog, showing their support for Australians living with dementia. 100 people walked, ran and jogged on Saturday 10 February raising more than $10,000!

 

Dementia Australia CEO Maree McCabe AM said it was a wonderful occasion and extended her gratitude to all who participated, raised funds, spread the word and donated.

 

“There was an outstanding show of support from the Mudgee community who turned out in such large numbers for another year. So many people impacted by dementia find these events a great way to connect with others in similar circumstances. It is such an important day and your support means the world,” Ms McCabe said.

 

Ms McCabe also acknowledged everyone who volunteered.

“It is only through the hard work of our wonderful volunteers that the success of this event is possible.”

The Mudgee event is one of the 22 scheduled Memory Walk & Jogs taking place across Australia in 2024. Details on the remaining events in the series can be found at www.memorywalk.com.au

Dementia Australia is encouraging anyone unable to participate at one of our 22 events to consider organising their own group or individual walk or jog, with a MyWay event. More details can be found at www.memorywalk.com.au/get-involved/mw.

 

Walk or jog with us. We are in this together.

 

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.  

 

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au   

 

-Ends-

Media contacts: Ash Blakemore, Senior Media & Communications Advisor, 0448 170 672, ash.blakemore@dementia.org.au. Andrea Hogan, Media and Communications Manager, 0406 904 118, andrea.hogan@dementia.org.au

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

Media

More from this category

  • Medical Health Aged Care
  • 17/09/2024
  • 22:56
Ripple Therapeutics

Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management

- Collaboration to leverage AbbVie's eye care expertise and Ripple's innovative drug delivery platform to develop next-generation sustained release drug delivery implants for the treatment of glaucoma TORONTO, ON / ACCESSWIRE / September 17, 2024 / Ripple Therapeutics today announced a collaboration and option-to-license agreement with AbbVie to develop RTC-620, a next generation, fully biodegradable, sustained release drug delivery intracameral implant with repeat dosing capabilities to reduce intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). This collaboration leverages AbbVie's expertise in eye care and Ripple's innovative drug delivery platform.Ripple's patented technology platform is based on…

  • Medical Health Aged Care
  • 17/09/2024
  • 15:11
Galderma

Galderma Reaffirms Its Leadership in Dermatology With Extensive Presence at EADV 2024

Late-breaking presentations will reveal important new data from the phase III OLYMPIA and ARCADIA trials, including durability and long-term efficacy of nemolizumab in prurigo…

  • Contains:
  • Engineering, Medical Health Aged Care
  • 17/09/2024
  • 08:40
UNSW Sydney

New electricity-free soft robot could aid precise surgery

Biomedical engineers have developed a new soft robotic system that works without electricity or motors, allowing for more precise surgeries at lower cost. The…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.